|
Developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. |
Private |
2007 |
View Profile |
|
Disrupting the landscape of clinical diagnostics with T2MR. |
Private |
2006 |
View Profile |
|
|
Private |
2008 |
View Profile |
|
Extending the life saving benefits of organ transplantation to patients suffering from end-stage organ failure. |
Private |
2010 |
View Profile |
|
Discovering, developing, manufacturing and commercializing novel protein therapeutics for orphan diseases and cancer. |
Private |
2004 |
View Profile |
|
Developing biologics to target autoimmune/inflammatory diseases. |
Private |
2006 |
View Profile |
|
Advancing the science and technology of corneal crosslinking. |
Private |
2009 |
View Profile |
|
Developing a new class of highly selective targeted and programmable therapeutics called Accurins™. |
Private |
2007 |
View Profile |
|
Offering award-winning software and consulting. |
Private |
2004 |
View Profile |
|
Delivers solutions for rich-media communication. |
Private |
1999 |
View Profile |
|
Developing electronic design automation tool for high-performance virtual system prototypes |
Private |
2002 |
View Profile |
|
Developing powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and consumer sectors. |
Private |
2009 |
View Profile |
|
Pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. |
Private |
2011 |
View Profile |
|
Developing deliciously edible forms of packaging that enclose food or drinks in ways similar to how nature protects foods. |
Private |
2012 |
View Profile |
|
Developing a pipeline of innovative treatments for bladder diseases. |
Private |
2008 |
View Profile |
|
Creating novel and differentiated biotherapeutics: first-of-a-kind protein-based drugs. |
Private |
2008 |
View Profile |
|
Commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. |
Private |
2007 |
View Profile |
|
Leading the world in the development of forward osmosis based solutions for the treatment and desalination of high saline source waters. |
Private |
2009 |
View Profile |
|
Discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. |
Private |
2008 |
View Profile |
|
Developing innovative technology for the low-cost conversion of abundant biomass. |
Private |
2006 |
View Profile |